News

Invalda INVL Group Adjusts Shares to Comply with Regulations

Invalda INVL Group Adjusts Shares to Comply with Regulations

Invalda INVL Group's Recent Share Sale Explained

Invalda INVL, the prominent asset management group in the Baltic region, has taken significant steps to maintain compliance with regulatory requirements. Recently, the group sold 2 million shares of Artea Bank, which equates to 0.3% of the bank's authorized capital, at a price of EUR 0.88 per share. This move was essential for Invalda INVL to remain within the 20% shareholding limit imposed by the European Central Bank.

Explanation Behind the Share Adjustment

According to Darius Šulnis, the CEO of Invalda INVL, Artea Bank decided to annul its previously held own shares and reduce its authorized capital. This decision prompted Invalda INVL Group to sell a portion of its shares to adhere to the bank's new regulations. The transaction was conducted over-the-counter (OTC), which means it did not have any impact on the market price of the bank's shares.

Impact of the Shareholding Structure

On March 31, 2025, a decision was made during Artea Bank’s shareholders' meeting to annul 10,597,749 shares, consequently lowering the bank's authorized capital to EUR 189,195,680. If Invalda INVL had not sold these shares, their ownership stake would have inflated to 20.25% after the capital reduction, surpassing the set regulatory threshold.

Current Shareholding in Artea Bank

As it stands, Invalda INVL Group maintains a 19.93% shareholding in Artea Bank. This strategic sale not only aligns with compliance protocols but also illustrates the group's commitment to sound governance practices.

Contact Information

For those seeking more information regarding this transaction, Darius Šulnis, CEO of Invalda INVL, is available for inquiries at the following email: Darius.Sulnis@invl.com.

Frequently Asked Questions

Why did Invalda INVL sell its shares in Artea Bank?

Invalda INVL sold shares to comply with the 20% shareholding limit set by the European Central Bank after Artea Bank's decision to reduce its authorized capital.

What was the price per share during the sale?

The shares were sold at a price of EUR 0.88 per share.

What percentage of Artea Bank does Invalda INVL currently own?

Invalda INVL currently holds 19.93% of the shares in Artea Bank.

How many shares did Artea Bank decide to annul?

Artea Bank decided to annul 10,597,749 of its shares as part of its capital reduction.

Who is the CEO of Invalda INVL?

The CEO of Invalda INVL is Darius Šulnis.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Advantech Ups the Ante in Robotics with GMSL Cameras

Updated Category News Views 240

Breaking Down Barriers in Robotics Vision Forget the robots of old; today’s machines need eyes sharper than a hawk just to keep up with the competition. Advantech (TWSE: 2395) isn’t just watching—they’re leading the pack with their GMSL Camera Enablement Scheme. They’re accelerating robotics from Autonomous Mobile Robots (AMRs) to humanoids, and it’s about...

Continue Reading
Insights on Stahla Services' Growth Strategies at WWETT 2026

Updated Category News Views 265

Leading the Charge in Sanitation Let me tell ya, if there's one thing that really grinds my gears in the business world, it's companies that just don't get it. But then there’s Stahla Services—man, they’re doing things right. At the recent WWETT Show in Indianapolis, held between February 16-19, 2026, Erin and Grant Stahla laid down some serious knowledge about...

Continue Reading
Cabana Pools Expands Reach with Cody's Pool Service

Updated Category News Views 217

Cabana Pools Expands Its Family with Cody's Pool Service Cabana Pool Service is thrilled to share the exciting news of its acquisition of Cody's Pool Service, a prominent family-owned business known for its reliable and exceptional pool care. For nearly three decades, Cody's Pool Service has been servicing communities, building a solid reputation on trust, expertise, and...

Continue Reading
Congress Urges FDA to Combat Counterfeit Weight-Loss Drugs

Updated Category News Views 276

Congress Takes Action Against Counterfeit Weight-Loss Drugs In a proactive move, a coalition of over 80 bipartisan members of Congress reached out to the U.S. Food and Drug Administration (FDA) Commissioner, emphasizing the urgent need to combat the influx of counterfeit and copycat GLP-1 drugs. Notable examples include Novo Nordisk A/S’ Wegovy (semaglutide) and Eli...

Continue Reading
Innovative NIH Grant for Anti-CCR5 Nanoparticle Development

Updated Category News Views 204

Aphios Secures NIH SBIR Grant for Alzheimer's Research Aphios has recently announced the exciting news of being awarded an NIH SBIR grant aimed at developing anti-CCR5 nanoparticles to combat Alzheimer’s disease. This initiative marks a significant step in advancing research and treatment options for one of the world's most pressing health challenges. Understanding...

Continue Reading